Home/Filings/4/0000899243-18-018105
4//SEC Filing

Urso David M 4

Accession 0000899243-18-018105

CIK 0001262104other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 2:27 PM ET

Size

5.5 KB

Accession

0000899243-18-018105

Insider Transaction Report

Form 4
Period: 2018-06-22
Urso David M
Sr. V.P. and General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-06-22+130,000130,000 total
    Exercise: $4.33Exp: 2028-06-22Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]One-quarter of such Options shall vest on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001604256

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 2:27 PM ET
Size
5.5 KB